All In Biotech

Free tool

FAERS Monitor: Bonsity

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 211939 or its brand name (Bonsity, Teriparatide). Reports on generic versions are filed under their own applications.

Reports

7,181

Serious

4,999

70% of reports

Hospitalization

2,528

Death reported

411

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • dizziness527
  • nausea525
  • fall505
  • fatigue487
  • back pain474
  • arthralgia462
  • device malfunction452
  • product dose omission issue436
  • pain in extremity425
  • pain398
  • headache391
  • device operational issue361
  • malaise299
  • asthenia280
  • dyspnoea239

Reports by year received

View as table
YearReports
200410
200533
200616
200757
200840
200952
201044
201185
2012307
2013509
2014150
2015142
2016129
2017310
2018437
2019492
2020228
2021185
2022299
2023476
2024986
20251,382
2026812

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,046,978 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
device operational issueSignal361268.2241.487,817
device malfunctionSignal45219.017.37,646
back painSignal4746.05.51,981
fallSignal5054.44.11,367
product dose omission issueSignal4364.34.01,135
pain in extremitySignal4254.23.91,058
arthralgiaSignal4623.33.0734
dizzinessSignal5273.12.9763
astheniaSignal2802.21.9181
malaise2992.01.8151
nausea5251.91.8249
pain3981.91.7173
fatigue4871.81.7190
headache3911.81.7150
dyspnoea2391.21.111

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.